In the degenerative CNS disease such as Alzheimer's disease (AD), subcutaneous injection with G-CSF would increase BMSCs mobilization to brain to rescue the lesions [39]. This evidence concerns the gene CSF3 and early-onset autosomal dominant Alzheimer disease.